3D-QSAR Study on dihydro-1,3,5-triazines and their spiro derivatives as DHFR inhibitors by comparative molecular field analysis (CoMFA).

PubWeight™: 0.76‹?›

🔗 View Article (PMID 22483391)

Published in Bioorg Med Chem Lett on March 16, 2012

Authors

Xiang Ma1, Guangya Xiang, Chun-Wei Yap, Wai-Keung Chui

Author Affiliations

1: School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, Hubei, China. maxwellcn@yahoo.com

Articles citing this

Treatment of acute lymphoblastic leukemia from traditional chinese medicine. Evid Based Complement Alternat Med (2014) 0.75

Articles by these authors

Antiproliferative, antiinvasive, and proapoptotic activity of folate receptor α-targeted liposomal doxorubicin in nonfunctional pituitary adenoma cells. Endocrinology (2013) 1.43

Anticonvulsant activity of phenylmethylenehydantoins: a structure-activity relationship study. J Med Chem (2004) 1.14

Design of a multifunctional PLGA nanoparticulate drug delivery system: evaluation of its physicochemical properties and anticancer activity to malignant cancer cells. Pharm Res (2009) 1.03

Role of formulation composition in folate receptor-targeted liposomal doxorubicin delivery to acute myelogenous leukemia cells. Mol Pharm (2007) 0.95

Shogaols at proapoptotic concentrations induce G(2)/M arrest and aberrant mitotic cell death associated with tubulin aggregation. Apoptosis (2011) 0.95

Folate receptor-targeted fluorescent paramagnetic bimodal liposomes for tumor imaging. Int J Nanomedicine (2011) 0.88

Folate receptor-targeted quantum dot liposomes as fluorescence probes. J Drug Target (2009) 0.85

Increase of doxorubicin sensitivity for folate receptor positive cells when given as the prodrug N-(phenylacetyl) doxorubicin in combination with folate-conjugated PGA. J Pharm Sci (2006) 0.85

Nanoparticulate delivery system targeted to tumor neovasculature for combined anticancer and antiangiogenesis therapy. Pharm Res (2010) 0.85

Identification of Michael acceptor-centric pharmacophores with substituents that yield strong thioredoxin reductase inhibitory character correlated to antiproliferative activity. Antioxid Redox Signal (2013) 0.84

Preparation, characterization and pharmacokinetics of folate receptor-targeted liposomes for docetaxel delivery. J Nanosci Nanotechnol (2009) 0.84

Integrin targeted drug and gene delivery. Expert Opin Drug Deliv (2010) 0.84

Preparation and in vitro evaluation of a folate-linked liposomal curcumin formulation. J Liposome Res (2012) 0.83

A high performance liquid chromatography method for the simultaneous determination of arctiin, chlorogenic acid and glycyrrhizin in a Chinese proprietary medicine. J Pharm Biomed Anal (2005) 0.83

In vitro and in vivo antitumor effects of folate-targeted ursolic acid stealth liposome. J Agric Food Chem (2014) 0.80

A novel shogaol analog suppresses cancer cell invasion and inflammation, and displays cytoprotective effects through modulation of NF-κB and Nrf2-Keap1 signaling pathways. Toxicol Appl Pharmacol (2013) 0.80

Ultrasound-triggered microbubble destruction in combination with cationic lipid microbubbles enhances gene delivery. J Huazhong Univ Sci Technolog Med Sci (2011) 0.80

Synthesis and in vitro evaluation of 2,4-diamino-1,3,5-triazine derivatives as neuronal voltage-gated sodium channel blockers. Bioorg Med Chem Lett (2009) 0.78

Identification of active compounds from medicinal plant extracts using gas chromatography-mass spectrometry and multivariate data analysis. J Sep Sci (2011) 0.78

Novel liposomal gefitinib (L-GEF) formulations. Anticancer Res (2012) 0.78

In vitro evaluation of a Folate-bovine serum albumin-doxorubicin conjugate. J Drug Target (2010) 0.76

Determination of sildenafil, vardenafil and aildenafil in human plasma by dispersive liquid-liquid microextraction-back extraction based on ionic liquid and high performance liquid chromatography-ultraviolet detection. J Chromatogr B Analyt Technol Biomed Life Sci (2013) 0.75

Antifolate and antiproliferative activity of 6,8,10-triazaspiro[4.5]deca-6,8-dienes and 1,3,5-triazaspiro[5.5]undeca-1,3-dienes. Bioorg Med Chem (2009) 0.75

Antiproliferative activity against MCF-7 breast cancer cells by diamino-triazaspirodiene antifolates. Chem Biol Drug Des (2009) 0.75

Synthesis and antimicrobial activity of N¹-benzyl or N¹-benzyloxy-1,6-dihydro-1,3,5-triazine-2,4-diamines. Bioorg Med Chem Lett (2011) 0.75

A structure-activity relationship study of 1,2,4-triazolo[1,5-a][1,3,5]triazin-5,7-dione and its 5-thioxo analogues on anti-thymidine phosphorylase and associated anti-angiogenic activities. Eur J Med Chem (2013) 0.75

Determination of imatinib mesylate and related compounds by field amplified sample stacking with large volume sample injection capillary electrophoresis. J Pharm Biomed Anal (2012) 0.75

Novel di-n-butyltin(IV) derivatives: Synthesis, high levels of cytotoxicity in tumor cells and the induction of apoptosis in KB cancer cells. Eur J Med Chem (2011) 0.75

Photoluminescence and X-ray excited luminescence from glutathione-stabilized gold nanoparticles. J Biomed Nanotechnol (2013) 0.75

Nonaqueous capillary electrophoresis of imatinib mesylate and related substances. J Sep Sci (2012) 0.75

Synthesis and in vitro evaluation of 1,2,4-triazolo[1,5-a][1,3,5]triazine derivatives as thymidine phosphorylase inhibitors. Chem Biol Drug Des (2013) 0.75